Scilex Holding Co. to Sell $10M in Stock and Warrants
Ticker: SCLXW · Form: 8-K · Filed: May 24, 2024 · CIK: 1820190
| Field | Detail |
|---|---|
| Company | Scilex Holding Co (SCLXW) |
| Form Type | 8-K |
| Filed Date | May 24, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financing, stock-offering, warrants
TL;DR
Scilex is selling $10M in stock/warrants, closing around May 29th.
AI Summary
Scilex Holding Company announced on May 24, 2024, that it has entered into a securities purchase agreement to sell approximately $10 million of its common stock and warrants. This offering is expected to close on or about May 29, 2024, and is subject to customary closing conditions.
Why It Matters
This capital raise could provide Scilex with necessary funds for operations or future development, potentially impacting its stock value and ability to execute its business strategy.
Risk Assessment
Risk Level: medium — Selling stock and warrants can dilute existing shareholders and indicates a need for capital, which may signal financial pressure.
Key Numbers
- $10.0M — Securities Sale (Amount of common stock and warrants to be sold in the offering.)
- May 29, 2024 — Closing Date (Anticipated date for the completion of the securities purchase agreement.)
Key Players & Entities
- Scilex Holding Company (company) — Registrant
- $10 million (dollar_amount) — Amount of securities to be sold
- May 24, 2024 (date) — Date of Report
- May 29, 2024 (date) — Expected closing date
FAQ
What is the purpose of selling approximately $10 million of common stock and warrants?
The filing does not explicitly state the purpose of the capital raise, but it is a common practice for companies to secure funding for operations, research and development, or other strategic initiatives.
Who is purchasing the common stock and warrants?
The filing does not specify the identity of the purchasers, referring to them generally as parties to a securities purchase agreement.
What are the specific terms of the warrants being sold?
The filing mentions the sale of warrants but does not provide specific details regarding their exercise price, expiration date, or other terms.
Are there any specific conditions that must be met before the closing on May 29, 2024?
Yes, the closing is subject to customary closing conditions, though the filing does not detail what these specific conditions are.
Has Scilex Holding Company previously engaged in similar capital raises?
This filing does not provide historical context on previous capital raises by Scilex Holding Company.
Filing Stats: 588 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-05-24 09:30:22
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share SCLX The Nasdaq Stock Mar
- $11.50 — mon stock, each at an exercise price of $11.50 per share SCLXW The Nasdaq Stock Ma
Filing Documents
- d828140d8k.htm (8-K) — 27KB
- d828140dex991.htm (EX-99.1) — 14KB
- g828140g0524032547511.jpg (GRAPHIC) — 5KB
- g828140g0524032547804.jpg (GRAPHIC) — 1KB
- g828140g0524032548021.jpg (GRAPHIC) — 1KB
- g828140g0524032548232.jpg (GRAPHIC) — 1KB
- 0001193125-24-146597.txt ( ) — 214KB
- sclxw-20240524.xsd (EX-101.SCH) — 4KB
- sclxw-20240524_def.xml (EX-101.DEF) — 13KB
- sclxw-20240524_lab.xml (EX-101.LAB) — 22KB
- sclxw-20240524_pre.xml (EX-101.PRE) — 14KB
- d828140d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated May 24, 2024. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Jaisim Shah Name: Jaisim Shah Title: Chief Executive Officer and President Date: May 24, 2024 3